's state-of-the-art lecture at #SLDSummit highlighted the global effort to redefine the nomenclature of liver diseases, transitioning from "NAFLD" to a more inclusive framework of steatotic liver disease. This change addresses stigma and incorporates the roles of both alcohol consumption and metabolic dysfunction, emphasising a spectrum rather than distinct conditions. 

⭐️The new terminology aims to reduce marginalisation, enhance patient communication, and maintain continuity in research and drug development. 

🫂 It promotes holistic, multidisciplinary care and opens new avenues for research on alcohol and metabolic interactions. The nomenclature is adaptable to evolving knowledge, supporting awareness, policy advocacy, and better integration of liver disease into broader public health priorities.
#SLDSummit